IceCure Medical (ICCM) Cash & Current Investments (2020 - 2026)

IceCure Medical (ICCM) has reported Cash & Current Investments for 7 consecutive years, with $12.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Current Investments rose 123.56% year-over-year to $12.0 million in Q2 2026; TTM through Jun 2026 was $12.0 million, a 123.56% increase from a year earlier, with the FY2025 full-year figure at $8.9 million, up 17.62% from the prior year.
• Cash & Current Investments was $12.0 million for Q2 2026 at IceCure Medical, up from $8.1 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $24.0 million in Q4 2022 and troughed at $504000.0 in Q4 2023.
• A 5-year average of $10.8 million and a median of $10.2 million in 2024 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments sank 97.9% in 2023 and jumped 1400.79% in 2024, its largest moves.
• Over 5 years, Cash & Current Investments stood at $24.0 million in 2022, then slumped by 97.9% to $504000.0 in 2023, then jumped by 1400.79% to $7.6 million in 2024, then increased by 17.62% to $8.9 million in 2025, then soared by 35.26% to $12.0 million in 2026.
• The last three Cash & Current Investments figures came in at $12.0 million (Q2 2026), $8.1 million (Q1 2026), and $8.9 million (Q4 2025), per Business Quant data.